Ultra-high-cost therapies are redefining pharmacy economics and reimbursement complexity. This panel explores how organizations are managing PBM relationships and payment models to ensure access while controlling financial risk. Leaders discuss contracting strategies, outcomes-based arrangements, utilization management, and collaboration approaches that balance affordability, innovation, and patient access.